| Target and Pathway |
Top |
| Target(s) |
GTPase NRas (NRAS) |
Target Info
|
Inhibitor |
[1] |
|
Pathwhiz Pathway
|
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine
|
|
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
|
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
|
Insulin Signalling
|
|
Reactome
|
SOS-mediated signalling
|
|
Activation of RAS in B cells
|
|
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
|
|
SHC1 events in ERBB2 signaling
|
|
SHC1 events in ERBB4 signaling
|
|
p38MAPK events
|
|
GRB2 events in EGFR signaling
|
|
SHC1 events in EGFR signaling
|
|
GRB2 events in ERBB2 signaling
|
|
Tie2 Signaling
|
|
EGFR Transactivation by Gastrin
|
|
DAP12 signaling
|
|
SHC-related events triggered by IGF1R
|
|
FCERI mediated MAPK activation
|
|
NCAM signaling for neurite out-growth
|
|
EPHB-mediated forward signaling
|
|
VEGFR2 mediated cell proliferation
|
|
CD209 (DC-SIGN) signaling
|
|
Constitutive Signaling by EGFRvIII
|
|
SHC-mediated cascade:FGFR1
|
|
FRS-mediated FGFR1 signaling
|
|
SHC-mediated cascade:FGFR2
|
|
FRS-mediated FGFR2 signaling
|
|
SHC-mediated cascade:FGFR3
|
|
FRS-mediated FGFR3 signaling
|
|
FRS-mediated FGFR4 signaling
|
|
SHC-mediated cascade:FGFR4
|
|
Regulation of RAS by GAPs
|
|
RAF activation
|
|
RAF/MAP kinase cascade
|
|
MAP2K and MAPK activation
|
|
Negative regulation of MAPK pathway
|
|
Insulin receptor signalling cascade
|
|
WikiPathways
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
|
DNA Damage Response (only ATM dependent)
|
|
TCR Signaling Pathway
|
|
ErbB Signaling Pathway
|
|
Senescence and Autophagy in Cancer
|
|
TGF Beta Signaling Pathway
|
|
IL-2 Signaling Pathway
|
|
Insulin Signaling
|
|
EGF/EGFR Signaling Pathway
|
|
MAPK Cascade
|
|
p38 MAPK Signaling Pathway
|
|
G Protein Signaling Pathways
|
|
Signaling of Hepatocyte Growth Factor Receptor
|
|
Kit receptor signaling pathway
|
|
Extracellular vesicle-mediated signaling in recipient cells
|
|
IL-3 Signaling Pathway
|
|
Bladder Cancer
|
|
Signaling by ERBB4
|
|
Signaling by ERBB2
|
|
Fc epsilon receptor (FCERI) signaling
|
|
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
|
|
Signaling by the B Cell Receptor (BCR)
|
|
RAF/MAP kinase cascade
|
|
Interleukin-2 signaling
|
|
Signaling by SCF-KIT
|
|
DAP12 interactions
|
|
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
|
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
|
Nanoparticle-mediated activation of receptor signaling
|
|
JAK/STAT
|
|
Aryl Hydrocarbon Receptor
|
|
PDGF Pathway
|
|
Alpha 6 Beta 4 signaling pathway
|
|
BDNF signaling pathway
|
|
Oncostatin M Signaling Pathway
|
|
Interleukin-11 Signaling Pathway
|
|
TNF alpha Signaling Pathway
|
|
B Cell Receptor Signaling Pathway
|
|
RalA downstream regulated genes
|
|
Prostate Cancer
|
|
Signaling Pathways in Glioblastoma
|
|
Leptin signaling pathway
|
|
TSH signaling pathway
|
|
Signaling by PDGF
|
|
Signaling by Insulin receptor
|
|
Signaling by FGFR
|
|
Signaling by EGFR
|
|
NGF signalling via TRKA from the plasma membrane
|
|
NCAM signaling for neurite out-growth
|
|
Integrin-mediated Cell Adhesion
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
Cell surface interactions at the vascular wall
|
